MDS, the parent company of radioisotope developer MDS Nordion of Kanata, Ontario, is the target of a New York City-based hedge fund that wants to break up the company to boost its stock price, according to the Calgary Herald.
Obrem Capital has filed a U.S. regulatory brief that claims it bought $6.2 million MDS shares, or 5% of the company, because it believes MDS is an attractive investment opportunity. Obrem now owns $125 million in MDS stock.
Related Reading
Reactor shutdown hurts MDS Nordion's Q1, March 6, 2008
MDS expects less impact from reactor shutdown, December 17, 2007
MDS Nordion divests two product lines, November 30, 2007
MDS Nordion signs cobalt-60 supply pact, October 19, 2007
MDS Nordion to help create molecular imaging center, June 5, 2007
Copyright © 2008 AuntMinnie.com
